Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features

被引:17
作者
Altobelli, E. [1 ]
Marziliano, C. [1 ]
Fargnoli, M. C. [2 ]
Petrocelli, R. [1 ]
Maccarone, M. [3 ]
Chimenti, S. [4 ]
Peris, K. [2 ]
机构
[1] Univ LAquila, Dept Internal Med & Publ Hlth, Laquila, Italy
[2] Univ LAquila, Dept Dermatol, Laquila, Italy
[3] Italian Assoc Psoriat Patients ADIPSO, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy
关键词
QUALITY-OF-LIFE; FOLLOW DERMATOLOGICAL TREATMENT; TOPICAL THERAPY; PATIENT; ADHERENCE; MEDICATION; IMPACT; PRESCRIPTIONS; MANAGEMENT;
D O I
10.1111/j.1468-3083.2011.04196.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Patient adherence is a key element for therapeutic success and represents a major concern for all healthcare professionals. Objective Aim of our study was to assess the frequency of use of treatments currently available for psoriasis and its association with specific socio-demographical and clinical variables. Methods The study population consisted of 1689 patients, aged 1285 years. Information concerning socio-demographical variables, clinical features and the type of current treatment was collected. Items on patients satisfaction of current treatments and of dermatologist-patient relationship were also included. The chi-squared test was used to estimate the association between the categorical variables, whereas Wilcoxon and KruskalWallis tests were applied to the interval and ordinal variables. The CochranMantelHaenszel chi-squared trend test was used to evaluate the degree of satisfaction related to dermatologistpatient relationship. Results Of the 1689 psoriatic patients, 54.1% did not use any treatments and 45.9% used at least one treatment. The use of drugs was significantly associated exclusively to severity of disease and affected body surface area. Systemic therapies, both traditional treatments and biological agents, were mainly used in patients with disease duration >10 years and disease severity. Treatment adherence was significantly associated to the degree of patients satisfaction of his/her relationship with the dermatologist. Alternative treatment such as over the counter medications and acupuncture were used by 33% of patients. Conclusion The majority of psoriatic patients do not use any treatments. However, treatment adherence significantly increases when dermatologists clarify the treatment schedule, inform patients and meet the patients needs.
引用
收藏
页码:976 / 982
页数:7
相关论文
共 25 条
[1]   Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication [J].
Andersson, K ;
Melander, A ;
Svensson, C ;
Lind, O ;
Nilsson, JLG .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2005, 15 (06) :621-626
[2]  
[Anonymous], 2013, Adherence to Long-Term Therapies: Evidence for Action, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.321-324.1779
[3]   Maximizing patient adherence for optimal outcomes in psoriasis [J].
Bewley, A. ;
Page, B. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 :9-14
[4]   Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: Commonly used methods of measuring adherence to topical therapy overestimate actual use [J].
Carroll, CL ;
Feldman, SR ;
Camacho, FT ;
Manuel, JC ;
Balkrishnan, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (02) :212-216
[5]   COMPLIANCE DECLINES BETWEEN CLINIC VISITS [J].
CRAMER, JA ;
SCHEYER, RD ;
MATTSON, RH .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (07) :1509-1510
[6]  
De Arruda LHF, 2001, BRIT J DERMATOL, V144, P33, DOI 10.1046/j.1365-2133.2001.00034.x
[7]   Psoriasis: Improving adherence to topical therapy [J].
Feldman, Steven R. ;
Horn, Elizabeth J. ;
Balkrishnan, Rajesh ;
Basra, Mohammad K. ;
Finlay, Andrew Y. ;
McCoy, Dan ;
Menter, Alan ;
van de Kerkhof, Peter C. M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (06) :1009-1016
[8]  
Feldman SR, 2010, J DRUGS DERMATOL, V9, P908
[9]   Initial phase of chronic medication use; patients' reasons for discontinuation [J].
Hugtenburg, JG ;
Blom, ATG ;
Kisoensingh, SU .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) :352-354
[10]   Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life [J].
Katugampola, RP ;
Hongbo, Y ;
Finlay, AY .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) :1256-1262